LFMD · LifeMD, Inc.
AI read · Neutral
The AI's read
The lower target points to less value in Mizuho's view, but its unchanged rating still favors LifeMD shares. The story gives no new sales, profit, or business results, so it does not show a clear change in the company's outlook.